durvalumab
Astrazeneca
['nsclc', 'sclc']
great discussion from and suresh senan on resectability in stage iii nsclc today . ed board members &amp; penned this recent review on challenges in unresectable stage iii #nsclc #esmo2022
A @SAGE_Publishing gold #openaccess journal | Publishing high-quality innovative studies/articles on the medical treatment of cancer| PubMed Indexed | IF: 5.485